Body mass index but not genetic risk is longitudinally associated with altered structural brain parameters.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 12 2021
Historique:
received: 29 06 2021
accepted: 17 11 2021
entrez: 21 12 2021
pubmed: 22 12 2021
medline: 26 2 2022
Statut: epublish

Résumé

Evidence from previous studies suggests that elevated body mass index (BMI) and genetic risk for obesity is associated with reduced brain volume, particularly in areas of reward-related cognition, e.g. the medial prefrontal cortex (AC-MPFC), the orbitofrontal cortex (OFC), the striatum and the thalamus. However, only few studies examined the interplay between these factors in a joint approach. Moreover, previous findings are based on cross-sectional data. We investigated the longitudinal relationship between increased BMI, brain structural magnetic resonance imaging (MRI) parameters and genetic risk scores in a cohort of n = 502 community-dwelling participants from the Study of Health in Pomerania (SHIP) with a mean follow-up-time of 4.9 years. We found that (1) increased BMI values at baseline were associated with decreased brain parameters at follow-up. These effects were particularly pronounced for the OFC and AC-MPFC. (2) The genetic predisposition for BMI had no effect on brain parameters at baseline or follow-up. (3) The interaction between the genetic score for BMI and brain parameters had no effect on BMI at baseline. Finding a significant impact of overweight, but not genetic predisposition for obesity on altered brain structure suggests that metabolic mechanisms may underlie the relationship between obesity and altered brain structure.

Identifiants

pubmed: 34930940
doi: 10.1038/s41598-021-03343-3
pii: 10.1038/s41598-021-03343-3
pmc: PMC8688483
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24246

Informations de copyright

© 2021. The Author(s).

Références

Int J Obes (Lond). 2015 Jan;39(1):85-97
pubmed: 24566855
Int J Epidemiol. 2011 Apr;40(2):294-307
pubmed: 20167617
Neuroimage. 2015 Nov 15;122:149-57
pubmed: 26256530
Hum Brain Mapp. 2014 Dec;35(12):5932-45
pubmed: 25081815
Mol Psychiatry. 2017 May;22(5):703-710
pubmed: 28348383
Rofo. 2009 Aug;181(8):748-59
pubmed: 19598074
Prog Mol Biol Transl Sci. 2016;140:151-84
pubmed: 27288829
Neuroimage. 2006 Jul 15;31(4):1419-25
pubmed: 16545583
Int J Obes (Lond). 2016 Jul;40(7):1177-82
pubmed: 27089992
Psychiatry Res. 2013 Nov 30;214(2):109-15
pubmed: 24041490
IEEE Trans Med Imaging. 1998 Feb;17(1):87-97
pubmed: 9617910
Clin Epigenetics. 2015 Jul 11;7:66
pubmed: 27408648
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Hum Brain Mapp. 2018 Aug;39(8):3398-3418
pubmed: 29696725
Nat Commun. 2019 Sep 11;10(1):4130
pubmed: 31511532
Int J Obes (Lond). 2019 May;43(5):943-951
pubmed: 30022057
Neurology. 2019 Feb 5;92(6):e594-e600
pubmed: 30626649
Eur J Neurol. 2013 Jun;20(6):899-906, e76-7
pubmed: 23323838
Br Med Bull. 2017 Sep 1;123(1):159-173
pubmed: 28910990
Neuroimage. 2016 Apr 15;130:214-222
pubmed: 26876474
Soc Cogn Affect Neurosci. 2019 Mar 5;14(3):319-327
pubmed: 30715518
Neurosci Biobehav Rev. 2020 Dec;119:468-480
pubmed: 33086131
Neuroimage Clin. 2019;21:101640
pubmed: 30553762
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4260-e4274
pubmed: 33677592
IEEE Trans Med Imaging. 2007 Apr;26(4):518-29
pubmed: 17427739
Hum Brain Mapp. 2016 Nov;37(11):3745-3756
pubmed: 27400738
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Brain Imaging Behav. 2020 Aug;14(4):1108-1117
pubmed: 30820858
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9312-9317
pubmed: 30154161
Hum Brain Mapp. 2011 Dec;32(12):2256-66
pubmed: 21305668
Nat Rev Neurosci. 2005 Sep;6(9):691-702
pubmed: 16136173
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
pubmed: 10984517
Nat Rev Neurosci. 2016 Aug;17(8):513-23
pubmed: 27256552
J Cogn Neurosci. 1993 Spring;5(2):162-76
pubmed: 23972151
Neuroimage. 2010 Nov 15;53(3):1135-46
pubmed: 20006715
Neuroimage. 2018 May 15;172:853-863
pubmed: 29107772
Biochim Biophys Acta. 2009 May;1792(5):395-400
pubmed: 18992327
Mol Psychiatry. 2021 Sep;26(9):4839-4852
pubmed: 32467648
Neuroimage Clin. 2020;28:102420
pubmed: 32961404
PeerJ. 2017 Jun 29;5:e3510
pubmed: 28674662
Transl Psychiatry. 2021 May 18;11(1):295
pubmed: 34006848
BMC Psychiatry. 2013 Apr 09;13:110
pubmed: 23570420
Neurosci Biobehav Rev. 2020 Jan;108:646-657
pubmed: 31794778
Biol Psychiatry. 2018 Nov 1;84(9):692-701
pubmed: 29910027
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Metabolism. 2019 Mar;92:98-107
pubmed: 30399375
IEEE Trans Med Imaging. 2001 Jan;20(1):70-80
pubmed: 11293693
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
JAMA. 2007 Apr 25;297(16):1819-22
pubmed: 17456824
Obes Surg. 2018 Aug;28(8):2578-2582
pubmed: 29876838
Nature. 2016 Aug 11;536(7615):171-178
pubmed: 27437579
Biol Psychiatry. 2015 Apr 1;77(7):624-32
pubmed: 25433902
BMC Med. 2015 Apr 17;13:86
pubmed: 25903154
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Neuroimage. 2011 Mar 1;55(1):296-303
pubmed: 21111829

Auteurs

Anne Tüngler (A)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Sandra Van der Auwera (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.
German Center for Neurodegenerative Diseases DZNE, Site Rostock/Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Katharina Wittfeld (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.
German Center for Neurodegenerative Diseases DZNE, Site Rostock/Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Stefan Frenzel (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Jan Terock (J)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.
Department of Psychiatry and Psychotherapy, HELIOS Hanseklinikum Stralsund, Rostocker Chaussee 70, 18437, Stralsund, Germany.

Nele Röder (N)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Georg Homuth (G)

Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Felix-Hausdorff-Str. 8, 17475, Greifswald, Germany.

Henry Völzke (H)

Institute for Community Medicine, University Medicine Greifswald, Walther-Rathenau-Str. 48, 17487, Greifswald, Germany.

Robin Bülow (R)

Department of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str., 17475, Greifswald, Germany.

Hans Jörgen Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.
German Center for Neurodegenerative Diseases DZNE, Site Rostock/Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany.

Deborah Janowitz (D)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany. Deborah.Janowitz@helios-gesundheit.de.
Department of Psychiatry and Psychotherapy, HELIOS Hanseklinikum Stralsund, Rostocker Chaussee 70, 18437, Stralsund, Germany. Deborah.Janowitz@helios-gesundheit.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH